Good evening :)
Add to Watchlist
Share

JM Midcap Fund

Growth
20.090.41% (+0.08)

How to use scorecard? Learn more

JM Midcap Fund

Growth
EquityMid Cap Fund
Mid-size FundAssets Under Mgmt: ₹ 1,696 Cr
Very High RiskPrinciple investment will be at very high risk
20.090.41% (+0.08)

Price Chart

High
—
Low
—
Returns
0.00%
1M
6M
1Y
3Y
5Y
Max
SIP
Loading...
1M
6M
1Y
3Y
5Y
Max
SIP

How to use scorecard? Learn more

EquityMid Cap Fund
Mid-size FundAssets Under Mgmt: ₹ 1,696 Cr
Very High RiskPrinciple investment will be at very high risk

Key Metrics

Expense RatioExpense RatioNo LabelNo LabelNo LabelNo Label
0.3955.601.61
No LabelNo LabelNo LabelNo LabelNo LabelNo Label
1.2958.071.47

Scheme Info

PlanPlanLock inLock inExit LoadExit Load
Growth0 yrs1.00%
1% on or before 180D Nil after 180D
SIP Inv.SIP Inv.Min. LumpsumMin. Lumpsum
Allowed₹ 1,000
Initial: ₹ 1,000 Incremental: ₹ 100
BenchmarkBenchmark
Nifty Midcap 150 - TRI

About Mid Cap Fund

Mid Cap funds invest in stocks of the companies ranking from 101-250 in terms of full market capitalization. They invest at least 65% of their assets in equity and equity related schemes of mid cap companies. These funds are less riskier than small-cap funds

Peers & Comparison

Comparing 3 mutual funds from 
EquityMid Cap Fund

Returns

Scheme

Ratios

Loading...
Mutual Fund1Y Returns1Y Returns3Y CAGR3Y CAGRLife CAGRLife CAGR
JM Midcap Fund37.27%—39.54%
HDFC Mid-Cap Opportunities Fund31.09%29.50%22.26%
Kotak Emerging Equity Fund36.53%25.00%22.21%
Nippon India Growth Fund30.60%27.65%19.84%

Price Comparison

Compare JM Midcap Fund with any MF, ETF, stock or index
Compare JM Midcap Fund with any MF, ETF, stock or index
JM Midcap Fund
Hmm, looks like data is unavailable here. Please come back after some time
Loading...

Asset Allocation

Actual

Target

Mar 2024

Jun 2024

Sep 2024

Nov 2024

ACTUAL
Cash & EquivalentsEquity0.55%99.45%

Mar 2024

Jun 2024

Sep 2024

Nov 2024

Tickertape Separator

Sector Distribution

+30 moreFertilizers & Agro ChemicalsElectrical Components & EquipmentsIT Services & ConsultingHome Electronics & AppliancesPharmaceuticals60.18 %5.79 %5.86 %6.87 %7.50 %13.79 %

Mar 2024

Jun 2024

Sep 2024

Nov 2024

Tickertape Separator

Sector Weightage

Sep 23Dec 23Mar 24Jun 24Sep 24Nov 244.91%2.34%10.60%9.90%14.58%13.79%
Pharmaceuticals as a % of total holdings for last six quarters
Tickertape Separator

Current Holdings

Equity

Others

  • Constituent
    Holding Weight
    3M Change
  • Biocon Ltd
    BIOCON
    3M change : 1.13 %

    Holdings

    2.95 %

    1.13 %
  • Federal Bank Ltd
    FEDERALBNK
    3M change : 2.93 %

    Holdings

    2.93 %

    2.93 %
  • Max Healthcare Institute Ltd
    MAXHEALTH
    3M change : 0.79 %

    Holdings

    2.91 %

    0.79 %

AMC Profile

JM Financial Asset Management Private Limited is one of the first privately operated mutual funds company, which commenced its operations back in 1993-94. It is a subsidiary of the much older JM Financial Group

  • No.of Schemes

    15

  • Total AUM

    ₹ 13,663.27 Cr.

Fund Manager Profile

Satish Ramanathan

AUM:  ₹9,885.11 Cr.

Sum of AUMs of all funds managed by the fund manager

 | 

Exp: 17.9yrs

Asit Bhandarkar

AUM:  ₹9,885.11 Cr.

Sum of AUMs of all funds managed by the fund manager

 | 

Exp: 11yrs

Chaitanya Choksi

AUM:  ₹9,885.11 Cr.

Sum of AUMs of all funds managed by the fund manager

 | 

Exp: 11yrs

Ruchi Fozdar

AUM:  ₹13,663.27 Cr.

Sum of AUMs of all funds managed by the fund manager

 | 

Exp: —

Manager Performance (0)

Loading...

Tax Implications

Invested period < 1 year

Gains are treated as short-term capital gains and taxed at 20%

Invested period > 1 year

Gains are treated as long-term capital gains and taxed at 12.5%

Let’s calculate your returns after tax

Investment frequency

Monthly

One Time

Monthly Investment Amt. (₹)

Investment period (years)

CAGR (%)
This CAGR is calculated based on the actual past return given by the fund during the selected investment period. This is the annualised growth rate assuming monthly compounding.

+

-

You make

Opinions and Fund Reviews

The content here in the form of articles and videos is for information purposes only and may have been sourced from publicly available sources or otherwise. Tickertape does not guarantee the authenticity and veracity of the material shared. The User understands and agrees that Tickertape is not aware nor liable for any content shared here.
Hmm, looks like data is unavailable here. Please come back after some time.